新型冠状病毒疫苗: 现状与展望
作者:
作者单位:

复旦大学附属公共卫生临床中心, 上海 201508

作者简介:

通讯作者:

张晓燕   E-mail: zhangxiaoyan@shphc.org.cn

中图分类号:

基金项目:


SARS-CoV-2 vaccines: current situation and prospect
Author:
Affiliation:

Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    新型冠状病毒肺炎的大流行严重威胁人类健康和发展,为应对这一全球性公共卫生事件,多种技术路线的新型冠状病毒疫苗(新冠疫苗)被投入紧急使用。本文介绍了新冠疫苗技术路线,并就新冠疫苗应对多种突变毒株的效力和在高危人群中的使用进行了梳理,发现现有疫苗对突变毒株效力出现了不同程度的下降,提示应关注突变毒株的影响。现有疫苗对高龄,孕妇等高风险人群缺乏足够的临床数据,应尽快开展针对高风险人群接种疫苗的相关研究。

    Abstract:

    The pandemic of coronavirus disease 2019 (COVID-19) seriously threatens human health and development. In response to this global public health event, SARS-CoV-2 vaccine with different techniques has been put into emergency use. This paper introduces the technique of SARS-CoV-2 vaccine, and elaborates the efficacy of COVID-19 vaccine against various mutant strains and its use in high-risk population. It is found that the effectiveness of the existing vaccines to mutant strains has declined to some extent, which suggests that the impact of mutant strains should be paid attention to. The existing vaccines lack sufficient clinical data for the elderly, pregnant women and other high-risk groups, so it is necessary to carry out research on vaccination for high-risk groups as soon as possible.

    参考文献
    相似文献
引用本文

杨天涵,张晓燕,徐建青.新型冠状病毒疫苗: 现状与展望[J]. 中国感染控制杂志,2021,(7):673-680. DOI:10.12138/j. issn.1671-9638.20211194.
Tian-han YANG, Xiao-yan ZHANG, Jian-qing XU. SARS-CoV-2 vaccines: current situation and prospect[J]. Chin J Infect Control, 2021,(7):673-680. DOI:10.12138/j. issn.1671-9638.20211194.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-08-04
  • 出版日期: